The G-Protein-Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis

被引:21
作者
Nikitenko, Leonid L. [1 ,3 ,4 ,8 ]
Leek, Russell [5 ]
Henderson, Stephen [1 ]
Pillay, Nischalan [2 ]
Turley, Helen [5 ]
Generali, Daniele [6 ,9 ]
Gunningham, Sarah [10 ]
Morrin, Helen R. [11 ]
Pellagatti, Andrea [5 ]
Rees, Margaret C. P. [7 ]
Harris, Adrian L. [6 ]
Fox, Stephen B. [12 ,13 ]
机构
[1] UCL, UCL Canc Inst, Canc Res UK Viral Oncol Grp, London, England
[2] UCL, UCL Canc Inst, Sarcoma Biol Grp, London, England
[3] Univ Oxford Keble Coll, Oxford OX1 3PG, England
[4] Univ Oxford Linacre Coll, Oxford OX1 1SY, England
[5] Nuffield Dept Clin Lab Sci, Oxford, England
[6] Weatherall Inst Mol Med, Canc Res UK Oncol Lab, Oxford, England
[7] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England
[8] Russian Acad Med Sci, Siberian Branch, Sci Ctr Family Hlth & Human Reprod Problems, Irkutsk, Russia
[9] Ist Ospitalieri Cremona, Unit Ctr Med Mol, Unita Patol Mammaria Senol Breast, Cremona, Italy
[10] Univ Otago, Dept Pathol, Christchurch, New Zealand
[11] Univ Otago, Canc Soc Tissue Bank, Christchurch, New Zealand
[12] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[13] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia
基金
英国惠康基金;
关键词
ANTI-ANGIOGENIC THERAPY; CANCER-RESEARCH; EXPRESSION; TUMORS; HYPOXIA; RESISTANCE; INDUCE;
D O I
10.1158/1078-0432.CCR-13-1712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The G-protein-coupled receptor (GPCR) calcitonin receptor-like receptor (CLR) and its ligand peptide adrenomedullin (encoded by ADM gene) are implicated in tumor angiogenesis in mouse models but poorly defined in human cancers. We therefore investigated the diagnostic/prognostic use for CLR in human tumor types that may rely on adrenomedullin signaling and in clear cell renal cell carcinoma (RCC), a highly vascular tumor, in particular. Experimental Design: In silico gene expression mRNA profiling microarray study (n = 168 tumors) and cancer profiling cDNA array hybridization (n = 241 pairs of patient-matched tumor/normal tissue samples) were carried out to analyze ADM mRNA expression in 13 tumor types. Immunohistochemistry on tissue microarrays containing patient-matched renal tumor/normal tissues (n = 87 pairs) was conducted to study CLR expression and its association with clinicopathologic parameters and disease outcome. Results: ADM expression was significantly upregulated only in RCC and endometrial adenocarcinoma compared with normal tissue counterparts (P < 0.01). CLR was localized in tumor cells and vessels in RCC and upregulated as compared with patient-matched normal control kidney (P < 0.001). Higher CLR expression was found in advanced stages (P < 0.05), correlated with high tumor grade (P < 0.01) and conferred shorter overall survival (P < 0.01). Conclusions: In human tissues ADM expression is upregulated in cancer type-specific manner, implicating potential role for adrenomedullin signaling in particular in RCC, where CLR localization suggests autocrine/paracrine mode for adrenomedullin action within the tumor microenvironment. Our findings reveal previously unrecognized CLR upregulation in an autocrine loop with adrenomedullin in RCC with potential application for this GPCR as a target for future functional studies and drug development. (C) 2013 AACR.
引用
收藏
页码:5740 / 5748
页数:9
相关论文
共 49 条
[1]  
[Anonymous], 2004, PATHOLOGY GENETICS T
[2]  
[Anonymous], 2005, BIOINFORMATICS COMPU
[3]   Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development [J].
Archbold, Julia K. ;
Flanagan, Jack U. ;
Watkins, Harriet A. ;
Gingell, Joseph J. ;
Hay, Debbie L. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (10) :591-600
[4]   Innovations and challenges in renal cell carcinoma: Summary statement from the second Cambridge conference [J].
Atkins, Michael B. ;
Ernstoff, Marc S. ;
Figlin, Robert A. ;
T Flaherty, Keith ;
George, Daniel J. ;
Kaelin, William G., Jr. ;
Kwon, Eugene D. ;
Libermann, Towia A. ;
Linehan, W. Marston ;
McDermott, David F. ;
Ochoa, Augusto C. ;
Pantuck, Allan J. ;
Rini, Brian I. ;
Rosen, Mark A. ;
Sosman, Jeffrey A. ;
Sukhatme, Vikas P. ;
Vieweg, Johannes W. ;
Wood, Christopher G. ;
King, Laura .
CLINICAL CANCER RESEARCH, 2007, 13 (02) :667S-670S
[5]   Automated uro-oncology data collection: the Cancer Research Uro-Oncology Database [J].
Charlesworth, Philip J. S. ;
Kilbey, Neviana ;
Taylor, Marian ;
Leek, Russell ;
Cranston, David ;
Turner, Gareth ;
Crew, Jeremy ;
Harris, Adrian ;
Protheroe, Andrew .
BJU INTERNATIONAL, 2010, 105 (12) :1663-1666
[6]  
Dawson C, 1996, BRIT MED J, V312, P1146
[7]   Translating cancer research into targeted therapeutics [J].
de Bono, J. S. ;
Ashworth, Alan .
NATURE, 2010, 467 (7315) :543-549
[8]   Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma [J].
Deville, Jean-Laurent ;
Bartoli, Catherine ;
Berenguer, Caroline ;
Fernandez-Sauze, Samantha ;
Kaafarani, Itidal ;
Delfino, Christine ;
Fina, Frederic ;
Salas, Sebastien ;
Muracciole, Xavier ;
Mancini, Julien ;
Lechevallier, Eric ;
Martin, Pierre-Marie ;
Figarella-Branger, Dominique ;
Ouafik, L'Houcine ;
Daniel, Laurent .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (10) :2307-2315
[9]   G-protein-coupled receptors and cancer [J].
Dorsam, Robert T. ;
Gutkind, J. Silvio .
NATURE REVIEWS CANCER, 2007, 7 (02) :79-94
[10]   Targeted therapy in renal cell carcinoma [J].
Favaro, JP ;
George, DJ .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (10) :1251-1258